| Fecal gluten peptides reveal limitations of serological tests and food questionnaires for monitoring gluten-free diet in celiac disease patients I Comino, F Fernández-Bañares, M Esteve, L Ortigosa, G Castillejo, ... The American journal of gastroenterology 111 (10), 1456, 2016 | 181 | 2016 |
| Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients IM Comino Montilla, F Fernández Bañares, V Segura Montero, ... American Journal of Gastroenterology, 111 (10), 1456-1465., 2016 | 181 | 2016 |
| Most patients with celiac disease on gluten-free diets consume measurable amounts of gluten JA Silvester, I Comino, CP Kelly, C Sousa, DR Duerksen, CN Bernstein, ... Gastroenterology 158 (5), 1497-1499. e1, 2020 | 56 | 2020 |
| Negative predictive value of the repeated absence of gluten immunogenic peptides in the urine of treated celiac patients in predicting mucosal healing: New proposals for follow … Á Ruiz-Carnicer, M Garzón-Benavides, B Fombuena, V Segura, ... The American journal of clinical nutrition 112 (5), 1240-1251, 2020 | 49 | 2020 |
| Prospective longitudinal study: use of faecal gluten immunogenic peptides to monitor children diagnosed with coeliac disease during transition to a gluten‐free diet I Comino, V Segura, L Ortigosa, B Espín, G Castillejo, JA Garrote, C Sierra, ... Alimentary pharmacology & therapeutics 49 (12), 1484-1492, 2019 | 47 | 2019 |
| Exposure sources, amounts and time course of gluten ingestion and excretion in patients with coeliac disease on a gluten‐free diet JA Silvester, I Comino, LN Rigaux, V Segura, KH Green, A Cebolla, ... Alimentary pharmacology & therapeutics 52 (9), 1469-1479, 2020 | 33 | 2020 |
| The dietary intervention of transgenic low-gliadin wheat bread in patients with non-celiac gluten sensitivity (NCGS) showed no differences with gluten free diet (GFD) but … C Haro, M Villatoro, L Vaquero, J Pastor, MJ Giménez, CV Ozuna, ... Nutrients 10 (12), 1964, 2018 | 29 | 2018 |
| The Dietary Intervention of Transgenic Low-Gliadin Wheat Bread in Patients with Non-Celiac Gluten Sensitivity (NCGS) Showed No Differences with Gluten Free Diet (GFD) but … C Haro, M Villatoro, L Vaquero, J Pastor, MJ Giménez, CV Ozuna Serafini, ... Nutrients, 10 (12, 1964), 1-15., 2018 | 29 | 2018 |
| Challenges of Monitoring the Gluten-Free Diet Adherence in the Management and Follow-Up of Patients with Celiac Disease H Wieser, Á Ruiz-Carnicer, V Segura, I Comino, C Sousa Nutrients 13 (7), 2274, 2021 | 25 | 2021 |
| Persistent villous atrophy in de novo adult patients with celiac disease and strict control of gluten-free diet adherence: A multicenter prospective study (CADER study) F Fernández-Bañares, B Beltrán, A Salas, I Comino, R Ballester-Clau, ... Official journal of the American College of Gastroenterology| ACG 116 (5 …, 2021 | 22 | 2021 |
| Food Safety and Cross-Contamination of Gluten-Free Products: A Narrative Review H Wieser, V Segura, Á Ruiz-Carnicer, C Sousa, I Comino Nutrients 13 (7), 2244, 2021 | 20 | 2021 |
| Celiac immunogenic potential of α-gliadin epitope variants from Triticum and Aegilops species Á Ruiz-Carnicer, I Comino, V Segura, CV Ozuna, ML Moreno, ... Nutrients 11 (2), 220, 2019 | 18 | 2019 |
| New Insights into Non-Dietary Treatment in Celiac Disease: Emerging Therapeutic Options V Segura, Á Ruiz-Carnicer, C Sousa, M de Lourdes Moreno Nutrients 13 (7), 2146, 2021 | 14 | 2021 |
| Rapid, effective, and versatile extraction of gluten in food with application on different immunological methods V Segura, J Díaz, Á Ruiz-Carnicer, A Muñoz-Suano, C Carrillo-Carrión, ... Foods 10 (3), 652, 2021 | 7 | 2021 |
| Oral Consumption of Bread from an RNAi Wheat Line with Strongly Silenced Gliadins Elicits No Immunogenic Response in a Pilot Study with Celiac Disease Patients MH Guzmán-López, S Sánchez-León, M Marín-Sanz, I Comino, V Segura, ... Nutrients 13 (12), 4548, 2021 | 5 | 2021 |
| Oral Consumption of Bread from an RNAi Wheat Line with Strongly Silenced Gliadins Elicits No Immunogenic Response in a Pilot Study with Celiac Disease Patients. Nutrients 2021 … MH Guzmán-López, S Sánchez-León, M Marín-Sanz, I Comino, V Segura, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 5* | 2021 |
| Corrigendum: Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients I Comino, F Fernández-Bañares, M Esteve, L Ortigosa, G Castillejo, ... Official journal of the American College of Gastroenterology| ACG 112 (7), 1208, 2017 | 2 | 2017 |
| Moreno, MdL New Insights into Non-Dietary Treatment in Celiac Disease: Emerging Therapeutic Options. Nutrients 2021, 13, 2146 V Segura, Á Ruiz-Carnicer, C Sousa s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 1 | 2021 |
| Oral enzyme strategy in celiac disease M de Lourdes Moreno, V Segura, Á Ruiz-Carnicer, AM Nájar, I Comino, ... Biotechnological Strategies for the Treatment of Gluten Intolerance, 201-220, 2021 | 1 | 2021 |
| New insights into non-dietary treatment in celiac disease: Emerging therapeutic options V Segura Montero, Á Ruiz Carnicer, C Sousa Martín, ML Moreno Amador Nutrients, 13 (7), 2146., 2021 | | 2021 |
